/assets/images/provider/photos/2863326.png)
By Suzanne Fenske, MD, FACOG, ABOIM, MSCP
If you haven’t changed your diet or exercise, but suddenly your cholesterol jumps 20 points and is now borderline or out of range, the reason why might surprise you: menopause.
Menopause itself is a risk factor for heart disease, as the hormonal changes during this transition drive metabolic shifts, including lipid changes, that account for some of the risk.
When a woman’s cholesterol becomes high in midlife, she usually receives the standard advice: exercise, watch saturated fat, and repeat labs in a year. What the advice may be missing is the bigger picture of menopause-driven cardiometabolic change. What’s missing is the hormone piece.
In today’s article, we’re going to discuss these cardiovascular shifts, with a focus on lipids, why it happens, and how to support healthy cholesterol and overall cardiometabolic health with disease prevention in mind. Continue reading to learn more about:
What is Cholesterol?
While cholesterol gets a bad rap, it’s an essential molecule for life. It provides essential structure to cell membranes and is the precursor to steroid hormones (including estrogen, testosterone, progesterone, and cortisol), vitamin D, and bile salts.
When we’re talking about measuring cholesterol in the blood, we’re actually talking about lipoproteins. Cholesterol, a lipophilic molecule, can’t travel in the blood by itself, so it’s packaged into lipoproteins along with fats (triglycerides) in the liver for transport around the body. These lipoproteins include:
High LDL cholesterol levels are associated with atherosclerotic plaques that may lead to heart disease. Low HDL levels, in the context of insulin resistance may also pose a risk factor.
Cardiometabolic and Lipid Changes in Menopause
Menopausal hormone changes, especially low estrogen (estradiol) levels, affect several cardiometabolic factors. In fact, earlier menopause often means greater cardiovascular risk. Menopause is associated with:
We often see cholesterol changes not as a gradual increase through perimenopause, but as a spike within a few years of menopause. Research suggests that, compared to pre-menopausal women, postmenopausal women may have:
Even women with genetically high cholesterol may see a more pronounced pattern after menopause than before.
Lp(a) is an interesting marker to follow. We typically think of this as a genetic marker of heart disease risk, but it also appears to have some non-genetic influences, including exercise, nutrition, and hormone status. Hormone replacement therapy in postmenopausal women may help lower Lp(a) levels however the science around Lp(a) management using lifestyle is emerging and it’s not currently at date of publication, a reliable intervention.
Estrogen, Cholesterol, and heart disease.
Heart disease remains the leading cause of death for women after menopause. Compared to men, this risk is still underestimated and under-researched, leading to worse care and prognosis.
Estrogen, particularly estradiol, is understood as a cardioprotective molecule. Women lose this protection with menopause.
Interestingly, the ovaries use LDL cholesterol to make estrogen. When the ovaries stop producing estrogen using this substrate, blood LDL levels can rise. That said, your body makes the cholesterol it needs; consuming extra cholesterol or saturated fat is not necessary for estrogen production and in fact increasing saturated fat above 6-10% (depending on your genetic history and health status) may increase risk for cardiometabolic risk both pre and post menopause. This is a reason to pay closer attention to heart health, not to increase saturated fat intake.
Another reason may include the fact that estradiol plays a role in fatty acid oxidation (turning fat into energy) in cellular mitochondria. In other words, fat burning may become less efficient in menopause, which could impact lipids.
An Integrative Strategy
Only 1 in 4 women know that menopause is associated with high cholesterol. So, our first order of business is to shout it from the rooftops so women can get the care they need.
Second, we must understand that high cholesterol and dyslipidemia are not isolated changes; they’re part of a larger cardiometabolic picture. By addressing the root causes, we can also support healthy body composition, blood sugar balance, insulin sensitivity, inflammation, and other factors. We want to catch imbalances early and ideally prevent heart disease and other chronic diseases altogether.
Therefore, lowering cholesterol isn’t the only goal. But lipids are modifiable and within your control, to some degree. Nutrition, lifestyle, and hormone therapy are powerful tools.
Here are some things you can do to support cholesterol levels and cardiometabolic health:
If you’ve noticed your cholesterol spike, consider it an opportunity to shift how you take care of yourself in midlife. It doesn’t need to be scary or complicated, and we’re here to help. Please reach out for a complete hormone and cardiometabolic assessment.
Declining estrogen levels during perimenopause and menopause affect how the body processes and regulates cholesterol. These hormonal changes can increase LDL cholesterol, triglycerides, and other cardiovascular risk factors, even when a woman's diet and exercise habits remain unchanged.
Yes. Cholesterol levels can begin changing during perimenopause as estrogen fluctuates. Some women experience a noticeable increase in cholesterol around their final menstrual period. Regular lipid testing can help identify these changes early and guide preventive care.
Estrogen influences cholesterol metabolism, fat distribution, and cardiovascular function. As estrogen declines during menopause, LDL cholesterol may increase, and the body may become more prone to insulin resistance and visceral fat accumulation. These changes can contribute to higher cardiovascular risk.
Yes. Menopause is associated with changes in cholesterol, blood pressure, insulin sensitivity, and body composition that can increase cardiovascular risk. Heart disease remains the leading cause of death among women, making cardiovascular prevention especially important during and after menopause.
A standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides. Depending on individual risk factors, additional testing may include apolipoprotein B (ApoB), lipoprotein(a), blood glucose or insulin assessments, and inflammatory markers. Coronary artery calcium scoring may also be appropriate for selected patients.
Menopausal hormone therapy can influence lipid levels, and some formulations may lower LDL cholesterol. However, hormone therapy is not recommended solely to treat high cholesterol or prevent cardiovascular disease. Decisions about hormone therapy should consider menopausal symptoms, medical history, cardiovascular risk, and individual treatment goals.
A heart-healthy dietary pattern emphasizes fiber-rich vegetables, fruits, legumes, whole grains, nuts, olive oil, and fish rich in omega-3 fatty acids. Reducing excess saturated fat and highly processed foods may also help improve cholesterol levels. Personalized nutrition recommendations can address additional concerns such as insulin resistance.
Regular physical activity can improve cardiovascular fitness, insulin sensitivity, body composition, and certain cholesterol measures. Combining aerobic exercise with resistance training is particularly valuable during menopause because it also helps preserve muscle mass and support metabolic health.
No. Although declining estrogen can contribute to cholesterol changes, genetics, thyroid disorders, insulin resistance, diet, medications, and other health factors may also play a role. A comprehensive evaluation helps identify contributing causes and determine appropriate treatment.
Integrative medicine evaluates cholesterol changes within the broader context of hormonal, metabolic, and cardiovascular health. At TārāMD, personalized care may include advanced risk assessment, functional nutrition, exercise and lifestyle interventions, appropriate medications, and menopause symptom management to support long-term health.